Pretzel Therapeutics

Pretzel Therapeutics was founded by leading academics in mitochondrial biology and is driven by a mission to develop life-changing medicines for patients and families affected by mitochondrial diseases. The company focuses on understanding and targeting the underlying causes of these diseases rather than just addressing symptoms. Pretzel Therapeutics leverages cutting-edge research in mitochondrial biology to discover and develop new treatments, aiming to create a new treatment paradigm in the field of mitochondrial therapeutics.

The company benefits from the leadership of experts in drug discovery, development, and company formation. Notable affiliated individuals include accomplished scientists and industry veterans who bring a wealth of experience to the organization. Pretzel Therapeutics has made significant strides in its field, contributing to a deeper understanding of mitochondrial diseases and advancing potential therapies. The impact of their work holds promise for improving the lives of thousands of people with genetic mitochondrial conditions.